We are live on ! Find out more
HBIO icon

Harvard Bioscience
HBIO

80 hedge funds and large institutions have $143M invested in Harvard Bioscience in 2018 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 28 increasing their positions, 26 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 8

23% more capital invested

Capital invested by funds: $116M → $143M (+$26.6M)

13% more funds holding

Funds holding: 71 → 80 (+9)

8% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 26

0.89% more ownership

Funds ownership: 6.54% → 7.43% (+0.89%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
80
Holders Change
+9
Holders Change %
+12.68%
% of All Funds
1.83%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
17
Increased
28
Reduced
26
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$7.71M
2
FLAM
First Light Asset Management
Minnesota
+$2.61M
3
State Street
State Street
Massachusetts
+$2.31M
4
Northern Trust
Northern Trust
Illinois
+$1.55M
5
RA
Royce & Associates
New York
+$1.38M

Top Sellers

Rank Fund Capital Flow
1
FP
Foundry Partners
Minnesota
-$1.22M
2
Millennium Management
Millennium Management
New York
-$847K
3
HA
Heartland Advisors
Wisconsin
-$812K
4
Macquarie Group
Macquarie Group
Australia
-$552K
5
Axa
Axa
France
-$491K
Name Holding Trade Value Shares
Change 		Change in
Stake
OAM
26
Oxford Asset Management
United Kingdom
$876K +$554K +10,819 +190%
JMPWA
27
JP Morgan Private Wealth Advisors
California
$872K +$835K +16,293 New
Bank of America
28
Bank of America
North Carolina
$787K -$4.66K -91 -0.6%
California Public Employees Retirement System
29
California Public Employees Retirement System
California
$745K – – –
Deutsche Bank
30
Deutsche Bank
Germany
$665K -$331K -6,471 -34%
AA
31
Ancora Advisors
Ohio
$650K -$141K -2,761 -19%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$636K +$392K +7,662 +182%
EI
33
EAM Investors
California
$600K -$105K -2,047 -15%
USAA
34
United Services Automobile Association
Texas
$599K – – –
WIC
35
Woodmont Investment Counsel
Tennessee
$508K -$90.7K -1,770 -16%
New York State Common Retirement Fund
36
New York State Common Retirement Fund
New York
$496K +$97.3K +1,900 +26%
Morgan Stanley
37
Morgan Stanley
New York
$463K +$91.7K +1,791 +26%
SO
38
STRS Ohio
Ohio
$424K +$407K +7,940 New
MERSOM
39
Municipal Employees' Retirement System of Michigan
Michigan
$421K – – –
Charles Schwab
40
Charles Schwab
California
$367K +$252K +4,929 +255%
TCIM
41
TIAA CREF Investment Management
New York
$366K +$351K +6,846 New
Millennium Management
42
Millennium Management
New York
$323K -$847K -16,527 -73%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$288K +$275K +5,377 New
TA
44
Teachers Advisors
New York
$244K +$234K +4,559 New
Wells Fargo
45
Wells Fargo
California
$196K +$3.94K +77 +2%
SIM
46
Spark Investment Management
New York
$177K -$46.1K -900 -21%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$164K +$157K +3,069 New
Manulife (Manufacturers Life Insurance)
48
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$160K +$150K +2,937 +5,994%
MSL
49
Mackay Shields LLC
New York
$160K +$153K +2,980 New
PP
50
PDT Partners
New York
$147K -$15.4K -300 -10%
1
2
3 4

HBIO Hedge Fund Activity: Q2 2018 in Review

80 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Harvard Bioscience (HBIO) for Q2 2018, worth a combined $143M — up 23% from $116M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new HBIO positions and 8 closed out — a net gain of 9 holders — while 28 added to existing stakes and 26 trimmed.

The largest buyer was BlackRock, adding an estimated $7.71M. The largest seller was Foundry Partners, cutting an estimated $1.22M.

  • 80 institutional investors held Harvard Bioscience (HBIO) as of Q2 2018, up from 71 in Q1 2018.
  • Funds reported $143M of Harvard Bioscience stock for Q2 2018, up 23% quarter-over-quarter.
  • 17 funds opened new Harvard Bioscience positions in Q2 2018 and 8 closed out, a net change of +9 holders.
  • The largest Harvard Bioscience buyer in Q2 2018 was BlackRock, an estimated $7.71M added.
  • The largest Harvard Bioscience seller in Q2 2018 was Foundry Partners, an estimated $1.22M sold.

Based on aggregated 13F filings for Q2 2018.